跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sulfobutylether-beta-cyclodextrin
首页
药物
Sulfobutylether-beta-cyclodextrin
Investigational
Small Molecule
Sulfobutylether-beta-cyclodextrin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
CAS 编号
182410-00-0
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
AN ORAL LIQUID COMPOSITION OF VINORELBINE
EP 4598589 A1
申请人: ROUSSY INST GUSTAVE
优先权: 2022
EP
US
WO
3 件公开
INCLUSION COMPOUNDS OF FUMAGILLOL DERIVATIVE OR ITS SALT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
US 2008085929 A1
申请人: KIM JAE HYUN
优先权: 2002
US
2 件公开
Lyophilized preparation of cytotoxic dipeptides
CN 108096563 A
申请人: ONCOPEPTIDES AB
优先权: 2011
CN
2 件公开
Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
US 6218375 B1
申请人: BRISTOL MYERS SQUIBB CO
优先权: 2000
US
Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof
US 8426385 B2
申请人: REN YONG
优先权: 2006
US
Water-soluble pharmaceutical composition containing edaravone/cyclodextrin inclusion compound
CN 104257603 A
申请人: UNIV NANJING NORMAL
优先权: 2010
CN
Injection ambroxol hydrochloride composition
CN 102600087 A
申请人: SHENYANG XINMA PHARMACEUTICAL CO LTD
优先权: 2012
CN
PREPARATION OF A COMPOSITION COMPRISING ALLOPREGNANOLONE AND SULFOBUTYLETHER-BETA-CYCLODEXTRIN
EP 3957309 A1
申请人: SAGE THERAPEUTICS INC
优先权: 2012
EP
Medicinal composition containing diclofenac sodium and preparation method thereof
CN 102871995 A
申请人: JIANGSU HANCHEN PHARMACEUTICAL CO LTD
优先权: 2012
CN
Enrofloxacin/sulfobutylether-beta-cyclodextrin inclusion compound, preparation method and medicinal preparation thereof
CN 102921018 A
申请人: CHONGQING ACADEMY ANIMAL SCI
优先权: 2012
CN
第 1 / 2 页
上一页
下一页
药物
反馈